|
Volumn 26, Issue 3, 1998, Pages
|
The amyloid precursor protein (APP) and the angiotensin converting enzyme (ACE) secretase are inhibited by hydroxamic acid-based inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID PRECURSOR PROTEIN;
ANGIOTENSIN CONVERTING ENZYME SECRETASE;
ASPARTIC PROTEINASE;
BACE1 PROTEIN, HUMAN;
BATIMASTAT;
BB 2116;
DIPEPTIDYL CARBOXYPEPTIDASE;
DRUG DERIVATIVE;
HYDROXAMIC ACID;
MARIMASTAT;
PHENYLALANINE;
PROTEINASE;
PROTEINASE INHIBITOR;
SECRETASE;
THIOPHENE DERIVATIVE;
ARTICLE;
BIOSYNTHESIS;
CELL CULTURE;
CELL LINE;
CYTOLOGY;
DRUG EFFECT;
HUMAN;
METABOLISM;
PROTEIN PROCESSING;
UMBILICAL VEIN;
VASCULAR ENDOTHELIUM;
AMYLOID BETA-PROTEIN PRECURSOR;
AMYLOID PRECURSOR PROTEIN SECRETASES;
ASPARTIC ENDOPEPTIDASES;
CELL LINE;
CELLS, CULTURED;
ENDOPEPTIDASES;
ENDOTHELIUM, VASCULAR;
HUMANS;
HYDROXAMIC ACIDS;
PEPTIDYL-DIPEPTIDASE A;
PHENYLALANINE;
PROTEASE INHIBITORS;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
THIOPHENES;
UMBILICAL VEINS;
|
EID: 0032138161
PISSN: 03005127
EISSN: None
Source Type: Journal
DOI: 10.1042/bst026s242 Document Type: Article |
Times cited : (7)
|
References (8)
|